Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments
By JoNel Aleccia
The top 12 states using antibody therapies produced by Regeneron and Lilly — which research shows don’t work against the omicron variant — include several Southern states with some of the nation’s lowest vaccination rates, but also California, which ranks among the top 20 for fully vaccinated residents.
¿Por qué más adultos mayores no reciben los refuerzos contra covid?
By Liz Szabo
Según los CDC, aproximadamente 1 de cada 3 estadounidenses mayores de 65 años que completaron su ronda inicial de vacunación aún no han recibido la primera vacuna de refuerzo. Investigadores enfatizan que este grupo sigue teniendo el mayor riesgo de enfermedad grave y muerte por covid-19.
¿Puede la melatonina masticable resolver los problemas de algunas familias a la hora de dormir? Expertos aconsejan precaución
By Jenny Gold
Muchas familias están usando masticables de melatonina para hacer dormir hasta a bebés. Pediatras generan controversia.
After ‘Truly Appalling’ Death Toll in Nursing Homes, California Rethinks Their Funding
By Samantha Young
California wants to hold nursing homes accountable for the quality of care they provide by tying Medicaid funding more directly to performance. But the nursing home industry, an influential player in the Capitol, is gearing up for a fight.
Nursing Home Residents Overlooked in Scramble for Covid Antibody Treatments
By JoNel Aleccia
A federal allocation plan meant to ensure equitable distribution of powerful monoclonal antibody treatments for high-risk patients fails to prioritize nursing home residents, a population that remains particularly vulnerable even after vaccination.
